Insights

Gathering insights about IBT…

Similar companies to IBT

IBT Tech Stack

IBT uses 8 technology products and services including Wix, Google Cloud, RequireJS, and more. Explore IBT's tech stack below.

Wix
Content Management System
Google Cloud
Infrastructure As A Service
RequireJS
Javascript Frameworks
Choices
Javascript Libraries
X-Content-Type-Options
Web & Portal Technology
Google Analytics
Web Analytics
Adobe Fonts
Web Fonts
Apache HTTP Server
Web Servers

Media & News

Edgestream Partners L.P. Buys Shares of 74,061 Ibotta, Inc. $IBTA
Edgestream Partners L.P. purchased a new stake in shares of Ibotta, Inc. (NYSE: IBTA) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 74,061 shares of the company's stock, valued at approximately $2,711,000. Edgestream Partners L.P. owned 0.29% of Ibotta as of
Dec 05, 2025 | www.defenseworld.net
Ibotta: Performance Worsens In Q3
Ibotta, Inc. faces operational headwinds, leading to a cautious outlook on the stock. IBTA's recent quarterly results showed a notable earnings per share beat, but revenues declined by about 15% year-over-year. Shares have dropped significantly over the past year, yet current operational challenges prevent a Buy recommendation for IBTA at this time.
Nov 17, 2025 | seekingalpha.com
Ibotta and ABCS Insights Announce Partnership to Advance Campaign Measurement for Digital Promotions
DENVER--(BUSINESS WIRE)--ABCS Insights, a leading ad effectiveness analytics company, and Ibotta (NYSE: IBTA), the performance marketing platform for promotions, today announced a partnership that provides CPG brands another way to measure how Ibotta's promotional campaigns drive profitable revenue growth. Initial studies for brands within the salty snack, pet food and carbonated beverage categories demonstrated Ibotta's ability to deliver sales lift higher than benchmarks for other digital med.
Nov 17, 2025 | www.businesswire.com
Johnson Fistel, PLLP Investigates Claims on Behalf of Ibotta, Inc. Long-Term Shareholders
SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of Ibotta, Inc. (NYSE: IBTA) shareholders against certain of its officers and directors who may have breached the fiduciary duties they owed to the Company. If you purchased Ibotta, Inc. shares on or shortly after the company's April 18, 2024 IPO, and still hold shares today, you may have certain legal rights. You are encouraged to learn more or submit your information at: https://www.johnsonfistel.com/investigations/ibotta-inc-3/ A federal securities fraud class action complaint alleges that statements made in Ibotta's Registration Statement issued in connection with its April 18, 2024 initial public offering were false and/or misleading when made. Specifically, the complaint alleges that Ibotta failed to properly warn investors of the risks concerning its contract with The Kroger Co. The Kroger contract was at-will, meaning a large client could terminate it without notice. Although Ibotta disclosed detailed terms of its contract with Walmart, it did not provide a single warning about the at-will nature of the Kroger agreement. What You Can Do Now: If you purchased Ibotta, Inc. shares on or shortly after the April 18, 2024 IPO, and still hold shares today, you are encouraged to visit https://www.johnsonfistel.com/investigations/ibotta, contact Johnson Fistel, PLLP at (619) 814-4471, or email jimb@johnsonfistel.com. You may be eligible to seek corporate reforms, the return of funds to the Company, and a court-approved incentive award at no cost to you. About Johnson Fistel, PLLP:Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm representing individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content. Contact:Johnson Fistel, PLLP501 W. Broadway, Suite 800, San Diego, CA 92101James Baker, Investor Relations or Frank J. Johnson, Esq.(619) 814-4471 | jimb@johnsonfistel.com or fjohnson@johnsonfistel.com
Nov 17, 2025 | www.globenewswire.com
Ibotta to Participate in Upcoming Investor Conferences
DENVER--(BUSINESS WIRE)--Ibotta (NYSE: IBTA), the performance marketing platform for promotions, announced today that company executives will participate in the following investor events: On Tues., November 18 at 3 p.m. PT / 6 p.m. ET, Chief Revenue Officer, Chris Riedy, will participate in a fireside chat at the Wells Fargo TMT Summit. On Wed., December 3 at 2:35 p.m. PT / 5:35 p.m. ET, Chief Executive Officer and founder, Bryan Leach, will participate in a fireside chat at UBS Global Technolo.
Nov 13, 2025 | www.businesswire.com
Ibotta Faces Revenue Decline Amid Economic Challenges; Strategic Initiatives Announced
Ibotta (IBTA) exceeded Q3 EPS and revenue expectations, but experienced a 15.5% year-over-year revenue drop to $83.3 million, marking its largest decline since
Nov 13, 2025 | www.gurufocus.com
Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday.
Nov 13, 2025 | www.benzinga.com

IBT's Email Address Formats

IBT uses at least 1 format(s):

IBT Email Formats	Example	Percentage
First@i-biomed.com	John@i-biomed.com	83%
FLast@i-biomed.com	JDoe@i-biomed.com	6%
First.Last@i-biomed.com	John.Doe@i-biomed.com	5%
First@i-biomed.com	John@i-biomed.com	6%

Frequently Asked Questions

What is IBT's phone number?

You can contact IBT's main corporate office by phone at

+1-443-451-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is IBT's stock symbol?

IBT is a publicly traded company; the company's stock symbol is IBTA.

What is IBT's official website and social media links?

IBT's official website is i-biomed.com and has social profiles on LinkedIn.

How much revenue does IBT generate?

As of December 2025, IBT's annual revenue is estimated to be $6M.

What is IBT's NAICS code?

IBT's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does IBT have currently?

As of December 2025, IBT has approximately 60 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Operating Officer: D. S.Business Development Manager: T. G.Marketing Manager: T. Z.. Explore IBT's employee directory with LeadIQ.

What industry does IBT belong to?

IBT operates in the Medical Equipment Manufacturing industry.

What technology does IBT use?

IBT's tech stack includes WixGoogle CloudRequireJSChoicesX-Content-Type-OptionsGoogle AnalyticsAdobe FontsApache HTTP Server.

What is IBT's email format?

IBT's email format typically follows the pattern of First@i-biomed.com. Find more IBT email formats with LeadIQ.

When was IBT founded?

IBT was founded in 1997.

IBT

Q: What is IBT's official website and social media links?

IBT's official website is i-biomed.com. IBT has social profiles on LinkedIn.

Q: How many employees does IBT have currently?

IBT has approximately 60 employees.

Q: What technology does IBT use?

IBT's tech stack includes Google Cloud, Sirvoy, Google Fonts API, Apache HTTP Server, Envoy.

Medical Equipment ManufacturingMaryland, United States51-200 Employees

Building innovative, streamlined solutions for people with upper limb loss and difference since 1997. Discover more at i-biomed.com.

Company Overview

Phone number: +1-443-451-****
Website: i-biomed.com
Stock Symbol: IBTA
NAICS Code: 3391 - Medical Equipment and Supplies Manufacturing
Founded: 1997
Employees: 51-200

Media & News

Funding & Financials

$1M$10M
IBT's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
IBT's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to IBT

axogen

Applied Biological Materials

Pollogen

Misonix

Ally Bridge Group

PolarityTE

IBT Tech Stack

Media & News

Edgestream Partners L.P. Buys Shares of 74,061 Ibotta, Inc. $IBTA

Ibotta: Performance Worsens In Q3

Ibotta and ABCS Insights Announce Partnership to Advance Campaign Measurement for Digital Promotions

Johnson Fistel, PLLP Investigates Claims on Behalf of Ibotta, Inc. Long-Term Shareholders

Ibotta to Participate in Upcoming Investor Conferences

Ibotta Faces Revenue Decline Amid Economic Challenges; Strategic Initiatives Announced

Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

IBT's Email Address Formats

Frequently Asked Questions

What is IBT's phone number?

What is IBT's stock symbol?

What is IBT's official website and social media links?

How much revenue does IBT generate?

What is IBT's NAICS code?

How many employees does IBT have currently?

What industry does IBT belong to?

What technology does IBT use?

What is IBT's email format?

When was IBT founded?

IBT

Company Overview

Media & News

Edgestream Partners L.P. Buys Shares of 74,061 Ibotta, Inc. $IBTA

Ibotta: Performance Worsens In Q3

Ibotta and ABCS Insights Announce Partnership to Advance Campaign Measurement for Digital Promotions

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?